NcXHF

TREATING OLDER ADULTS WITH CANCER
elderly: patterns, predictors, and related hospital use. Am J Public
Health. 1994;84:1274-1280.
22. Mir F, Zafar F, Rodin MB. Falls in older adults with cancer. Curr Geri
Rep. 2014;3:175-181.
23. Klepin HD, Pitcher BN, Ballman KV, et al. Comorbidity, chemotherapy
toxicity, and outcomes among older women receiving adjuvant chemotherapy
for breast cancer on a clinical trial: CALGB 49907 and CALGB
361004 (alliance). J Oncol Pract. 2014;10:e285-e292.
24. Fox C, Richardson K, Maidment ID, et al. Anticholinergic medication
use and cognitive impairment in the older population: the medical research
council cognitive function and ageing study. J Am Geriatr Soc.
2011;59:1477-1483.
25. Caillet P, Canoui-Poitrine F, Vouriot J, et al. Comprehensive geriatric
assessment in the decision-making process in elderly patients with cancer:
ELCAPA study. J Clin Oncol. 2011;29:3636-3642.
26. Kanesvaran R, Li H, Koo KN, et al. Analysis of prognostic factors of
comprehensive geriatric assessment and development of a clinical scoring
system in elderly Asian patients with cancer. J Clin Oncol. 2011;29:
3620-3627.
27. Soubeyran P, Fonck M, Blanc-Bisson C, et al. Predictors of early death
risk in older patients treated with fırst-line chemotherapy for cancer.
J Clin Oncol. 2012;30:1829-1834.
28. Sessums LL, Zembrzuska H, Jackson JL. Does this patient have medical
decision-making capacity? JAMA. 2011;306:420-427.
29. Deschodt M, Braes T, Flamaing J, et al. Preventing delirium in older
adults with recent hip fracture through multidisciplinary geriatric consultation.
J Am Geriatr Soc. 2012;60:733-739.
30. Flood KL, Carroll MB, Le CV, et al. Geriatric syndromes in elderly patients
admitted to an oncology-acute care for elders unit. J Clin Oncol.
2006;24:2298-2303.
31. Bush SH, Bruera E. The assessment and management of delirium in cancer
patients. Oncologist. 2009;14:1039-1049.
32. Landi F, Zuccalà G, Gambassi G, et al. Body mass index and mortality
among older people living in the community. J Am Geriatr Soc. 1999;47:
1072-1076.
33. Dewys WD, Begg C, Lavin PT, et al. Prognostic effect of weight loss prior
to chemotherapy in cancer patients. Eastern Cooperative Oncology
Group. Am J Med. 1980;69:491-497.
34. Mitchell AJ. Pooled results from 38 analyses of the accuracy of distress
thermometer and other ultra-short methods of detecting cancer-related
mood disorders. J Clin Oncol. 2007;10;25:4670-4681.
35. Stuck AE, Siu AL, Wieland GD, et al. Comprehensive geriatric assessment:
a meta-analysis of controlled trials. Lancet. 1993;342:1032-1036.
36. Cohen HJ. Cancer care in the older population: physiology of aging.
American Society of Clinical Oncology Curriculum 2002.
37. Flood KL, Carroll MB, Le CV, et al. Polypharmacy in hospitalized older
adult cancer patients: experience from a prospective, observational
study of an oncology-acute care for elders unit. Am J Geriatr Pharmacother.
2009;7:151-158.
38. Gallagher PF, O’Connor MN, O’Mahony D. Prevention of potentially
inappropriate prescribing for elderly patients: a randomized controlled
trial using STOPP/START criteria. Clin Pharmacol Ther. 2011;89:845-
854.
39. Maggiore RJ, Dale W, Gross CP, et al. Polypharmacy and potentially
inappropriate medication use in older adults with cancer undergoing
chemotherapy: effect on chemotherapy-related toxicity and hospitalization
during treatment. J Am Geriatr Soc. 2014;62:1505-1512.
40. Prithviraj GK, Koroukian S, Margevicius S, et al. Patient characteristics
associated with polypharmacy and inappropriate prescribing of medications
among older adults with cancer. J Geriatr Oncol. 2012;3:228-237.
41. Puts MT, Costa-Lima B, Monette J, et al. Medication problems in older,
newly diagnosed cancer patients in Canada: how common are they? A
prospective pilot study. Drugs Aging. 2009;26:519-536.
42. Hamaker ME, Mitrovic M, Stauder R. The G8 screening tool detects
relevant geriatric impairments and predicts survival in elderly patients
with a haematological malignancy. Ann Hematol. 2014;93:1031-1040.
43. Elliot K, Tooze JA, Geller R, et al. The prognostic importance of polypharmacy
in older adults treated for acute myelogenous leukemia
(AML). Leuk Res. 2014;38:1184-1190.
44. Popa MA, Wallace KJ, Brunello A, et al. Potential drug interactions and
chemotoxicity in older patients with cancer receiving chemotherapy.
J Geriatr Oncol. 2014;5:307-314.
45. Scher KS, Hurria A. Under-representation of older adults in cancer registration
trials: known problem, little progress. J Clin Oncol. 2012;30:
2036-2038.
46. Hurria A, Dale W, Mooney M, et al. Designing therapeutic clinical trials
for older and frail adults with cancer: U13 conference recommendations.
J Clin Oncol. 2014;32:2587-2594.
47. Clegg A, Young J, Iliffe S, et al. Frailty in elderly people. Lancet. 2013;
381:752-762.
48. Fried LP, Tangen CM, Walston J, et al. Frailty in older adults: evidence
for a phenotype. J Gerontol A Biol Sci Med Sci. 2001;56:M146-M156.
49. Song X, Mitnitski A, Rockwood K. Prevalence and 10-year outcomes of
frailty in older adults in relation to defıcit accumulation. J Am Geriatr
Soc. 2010;58:681-687.
50. Mohile SG, Fan L, Reeve E, et al. Association of cancer with geriatric
syndromes in older Medicare benefıciaries. J Clin Oncol. 2011;29:1458-
1464.
51. Owusu C, Koroukian SM, Schluchter M, et al. Screening older cancer
patients for a Comprehensive Geriatric Assessment: a comparison of
three instruments. J Geriatr Oncol. 2011;2:121-129.
52. Rodin MB, Mohile SG. A practical approach to geriatric assessment in
oncology. J Clin Oncol. 2007;25:1936-1944.
53. Soubeyran P, Bellera C, Goyard J, et al. Screening for vulnerability in
older cancer patients: the ONCODAGE Prospective Multicenter Cohort
Study. PLoS One. 2014;9:e115060.
54. Ramjaun A, Nassif MO, Krotneva S, et al. Improved targeting of cancer
care for older patients: a systematic review of the utility of comprehensive
geriatric assessment. J Geriatr Oncol. 2013;4:271-281.
55. Wildes TM, Ruwe AP, Fournier C, et al. Geriatric assessment is associated
with completion of chemotherapy, toxicity, and survival in older
adults with cancer. J Geriatr Oncol. 2013;4:227-234.
56. Terret C, Albrand G, Moncenix G, et al. Karnofsky Performance Scale
(KPS) or Physical Performance Test (PPT)? That is the question. Crit
Rev Oncol Hematol. 2011;77:142-147.
57. Bylow K, Hemmerich J, Mohile SG, et al. Obese frailty, physical performance
defıcits, and falls in older men with biochemical recurrence of
prostate cancer on androgen deprivation therapy: a case-control study.
Urology. 2011;77:934-940.
58. Klepin HD, Geiger AM, Tooze JA, et al. Physical performance and subsequent
disability and survival in older adults with malignancy: results
from the health, aging and body composition study. J Am Geriatr Soc.
2010;58:76-82.
59. Culine S, Terret C, Cupissol D, et al. Risk-adapted, dose escalation study
of weekly docetaxel in the fırst-line treatment of elderly patients with
advanced cancer. J Geriatr Oncol. 2013;4:122-127.
60. Temel JS, Greer JA, Muzikansky A, et al. Early palliative care for patients
with metastatic non-small-cell lung cancer. N Engl J Med. 2010;363:733-
742.
61. Hamaker ME, Schiphorst AH, ten Bokkel Huinink D, Schaar C, van
Munster BC. The effect of a geriatric evaluation on treatment decisions
for older cancer patients-a systematic review. Acta Oncol. 2014;53:289-
296.
asco.org/edbook | 2015 ASCO EDUCATIONAL BOOK
e551